tiprankstipranks
Summit Therapeutics PLC (SMMT)
NASDAQ:SMMT
US Market
SMMT
Summit Therapeutics
RESEARCH TOOLSreports
Want to see SMMT full AI Analyst Report?

Summit Therapeutics (SMMT) Income Statement

1,903 Followers

Summit Therapeutics Income Statement

Last quarter (Q1 2026), Summit Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Summit Therapeutics's net income was $-189.42M. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 583.19K$ 1.34M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 583.19K$ 1.34M
Operating Expenses
$ 1.09B$ 180.51M$ 478.23M$ 60.22M$ 65.07M
Depreciation and Amortization
$ 146.00K$ 71.00K$ 155.32K$ 1.04M$ 996.07K
EBITDA
$ -1.08B$ -168.46M$ -69.45M$ -51.58M$ -62.74M
Operating Income
$ -1.09B$ -180.51M$ -478.23M$ -59.63M$ -63.73M
Other Income/Expenses
$ 14.84M$ 3.74M$ -4.14M$ -5.54M$ -1.79M
Pretax Income
$ -1.08B$ -176.77M$ -482.37M$ -65.17M$ -65.52M
Net Income
$ -1.08B$ -176.77M$ -482.37M$ -65.17M$ -65.52M
Per Share Metrics
Basic EPS
$ -1.44$ -0.25$ -0.78$ -0.34$ -0.71
Diluted EPS
$ -1.44$ -0.25$ -0.78$ -0.34$ -0.71
Weighted Average Shares Outstanding
 747.70M 713.92M 619.64M 192.15M 92.24M
Weighted Average Shares Outstanding (Diluted)
 747.70M 718.54M 619.65M 193.34M 92.24M
Currency in USD

Summit Therapeutics Earnings and Revenue History